Hologic, Inc. (NASDAQ:HOLX) – Gabelli cut their FY2022 earnings per share (EPS) estimates for shares of Hologic in a report issued on Monday. Gabelli analyst S. Wojda now expects that the medical equipment provider will post earnings per share of $3.05 for the year, down from their previous estimate of $3.25.

Hologic (NASDAQ:HOLX) last announced its quarterly earnings data on Thursday, February 8th. The medical equipment provider reported $0.55 earnings per share for the quarter, beating analysts’ consensus estimates of $0.50 by $0.05. The firm had revenue of $791.10 million for the quarter, compared to analyst estimates of $785.80 million. Hologic had a net margin of 34.53% and a return on equity of 20.07%. The business’s quarterly revenue was up 7.7% compared to the same quarter last year. During the same period in the previous year, the company earned $0.52 earnings per share.

Other equities research analysts have also issued reports about the stock. Cowen raised shares of Hologic to a “buy” rating and set a $52.00 target price on the stock in a research note on Wednesday, December 20th. Deutsche Bank lowered shares of Hologic from a “buy” rating to a “hold” rating and set a $49.00 target price on the stock. in a research note on Friday, January 19th. Zacks Investment Research raised shares of Hologic from a “sell” rating to a “hold” rating in a research note on Tuesday, October 31st. Stifel Nicolaus lowered shares of Hologic from a “buy” rating to a “hold” rating and lowered their target price for the stock from $45.00 to $42.00 in a research note on Friday. Finally, Needham & Company LLC reissued a “buy” rating and set a $50.00 target price on shares of Hologic in a research note on Friday, November 3rd. One analyst has rated the stock with a sell rating, four have assigned a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company’s stock. Hologic currently has a consensus rating of “Buy” and a consensus target price of $48.00.

Shares of Hologic (NASDAQ HOLX) traded up $0.29 on Tuesday, hitting $38.04. 4,473,200 shares of the stock were exchanged, compared to its average volume of 3,002,262. Hologic has a 12-month low of $35.33 and a 12-month high of $46.80. The company has a quick ratio of 0.98, a current ratio of 1.25 and a debt-to-equity ratio of 0.87. The stock has a market capitalization of $10,438.97, a price-to-earnings ratio of 10.04, a PEG ratio of 1.71 and a beta of 0.77.

A number of hedge funds have recently added to or reduced their stakes in the business. Hall Laurie J Trustee raised its holdings in Hologic by 10.2% in the 2nd quarter. Hall Laurie J Trustee now owns 2,425 shares of the medical equipment provider’s stock valued at $110,000 after acquiring an additional 225 shares during the last quarter. Sentry Investment Management LLC raised its holdings in Hologic by 1.9% in the 2nd quarter. Sentry Investment Management LLC now owns 18,491 shares of the medical equipment provider’s stock valued at $839,000 after acquiring an additional 353 shares during the last quarter. Creative Planning raised its holdings in Hologic by 8.2% in the 4th quarter. Creative Planning now owns 15,396 shares of the medical equipment provider’s stock valued at $658,000 after acquiring an additional 1,161 shares during the last quarter. AT Bancorp raised its holdings in Hologic by 2.2% in the 4th quarter. AT Bancorp now owns 62,329 shares of the medical equipment provider’s stock valued at $2,664,000 after acquiring an additional 1,323 shares during the last quarter. Finally, State Board of Administration of Florida Retirement System increased its holdings in shares of Hologic by 0.3% during the 3rd quarter. State Board of Administration of Florida Retirement System now owns 406,630 shares of the medical equipment provider’s stock worth $14,919,000 after buying an additional 1,351 shares during the last quarter. Institutional investors own 93.84% of the company’s stock.

In other Hologic news, VP Karleen Marie Oberton sold 1,023 shares of the stock in a transaction dated Monday, November 20th. The shares were sold at an average price of $39.84, for a total value of $40,756.32. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.88% of the stock is owned by corporate insiders.

ILLEGAL ACTIVITY WARNING: This piece of content was originally posted by Watch List News and is owned by of Watch List News. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece of content can be viewed at https://www.watchlistnews.com/hologic-inc-to-post-fy2022-earnings-of-3-05-per-share-gabelli-forecasts-holx/1863973.html.

About Hologic

Hologic, Inc is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women’s health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The diagnostics products include Aptima family of assays, ThinPrep system, the Rapid Fetal Fibronectin Test and Procleix blood screening assays.

Earnings History and Estimates for Hologic (NASDAQ:HOLX)

Receive News & Ratings for Hologic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic and related companies with MarketBeat.com's FREE daily email newsletter.